ROSENWALD LINDSAY A MD (PRESIDENT AND CEO) received a stock award from FORTRESS BIOTECH, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/20/2026ACC: 0000941841-26-000002
DirectorOfficer10% Owner· PRESIDENT AND CEO
Since Jan 2018
+475.42K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
475.42K acquired
Non-Derivative Transactions1
Common stock, par value $0.001
Direct
Shares
+475.42K
Price / share
—
Trade value
—
% of position
11.6%
3/18/2026
4.11M→4.59M
Total
Net shares
+475.42K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 Direct | 3/18/2026 | A · Award | +475.42K | — | — | 11.6% | 4.11M | 4.59M |
| Total | +475.42K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported